CIK: 0001381843 · Show all filings
Period: Q1 2016 (← Previous) (Next →)
Filing Date: Apr 19, 2016
Total Value ($000): $213,576 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ANIK | ANIKA THERAPEUTICS INC | 490,331 | $21,928 | 10.3% | $38.50 | +5.4% | COM | 035255108 |
| — | FEI CO | 239,609 | $21,328 | 10.0% | $82.13 | — | COM | 30241L109 |
| — | LIFEPOINT HEALTH INC | 274,430 | $19,004 | 8.9% | $67.19 | — | COM | 53219L109 |
| — | GNC HLDGS INC | 586,955 | $18,636 | 8.7% | $31.02 | — | COM CL A | 36191G107 |
| — | AMAG PHARMACEUTICALS INC | 740,585 | $17,330 | 8.1% | $28.17 | — | COM | 00163U106 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 903,533 | $13,779 | 6.5% | $17.80 | -26.7% | COM | 868459108 |
| CRL | CHARLES RIV LABS INTL INC | 178,307 | $13,541 | 6.3% | $63.72 | +16.2% | COM | 159864107 |
| — | TARO PHARMACEUTICAL INDS LTD | 94,005 | $13,466 | 6.3% | $143.25 | — | SHS | M8737E108 |
| — | INC RESH HLDGS INC | 324,270 | $13,363 | 6.3% | $41.21 | — | CL A | 45329R109 |
| MRK | MERCK & CO INC NEW | 251,400 | $13,302 | 6.2% | $36.03 | 0.0% | COM | 58933Y105 |
| ELV | ANTHEM INC | 93,900 | $13,051 | 6.1% | $119.87 | -2.8% | COM | 036752103 |
| — | TRIPLE-S MGMT CORP | 503,826 | $12,525 | 5.9% | $19.58 | — | CL B | 896749108 |
| — | VALEANT PHARMACEUTICALS INTL | 370,000 | $9,731 | 4.6% | $26.30 | — | COM | 91911K102 |
| — | SYMMETRY SURGICAL INC | 316,427 | $3,120 | 1.5% | $8.67 | — | COM | 87159G100 |
| OSUR | ORASURE TECHNOLOGIES INC | 405,771 | $2,934 | 1.4% | $6.36 | 0.0% | COM | 68554V108 |
| — | DEPOMED INC | 200,000 | $2,786 | 1.3% | $13.93 | — | COM | 249908104 |
| — | SCICLONE PHARMACEUTICALS INC | 236,288 | $2,599 | 1.2% | $11.00 | — | COM | 80862K104 |
| ICCC | IMMUCELL CORP | 168,323 | $1,153 | 0.5% | $5.29 | +26.0% | COM PAR $0.10 | 452525306 |